Format
Sort by

Send to

Choose Destination

Search results

Items: 6

1.

Hsp90 inhibition suppresses NF-κB transcriptional activation via Sirt-2 in human lung microvascular endothelial cells.

Thangjam GS, Birmpas C, Barabutis N, Gregory BW, Clemens MA, Newton JR, Fulton D, Catravas JD.

Am J Physiol Lung Cell Mol Physiol. 2016 May 15;310(10):L964-74. doi: 10.1152/ajplung.00054.2016. Epub 2016 Apr 1.

PMID:
27036868
2.

Histone deacetylase inhibitors prevent pulmonary endothelial hyperpermeability and acute lung injury by regulating heat shock protein 90 function.

Joshi AD, Barabutis N, Birmpas C, Dimitropoulou C, Thangjam G, Cherian-Shaw M, Dennison J, Catravas JD.

Am J Physiol Lung Cell Mol Physiol. 2015 Dec 15;309(12):L1410-9. doi: 10.1152/ajplung.00180.2015. Epub 2015 Oct 23.

PMID:
26498249
3.

p53 protects against LPS-induced lung endothelial barrier dysfunction.

Barabutis N, Dimitropoulou C, Birmpas C, Joshi A, Thangjam G, Catravas JD.

Am J Physiol Lung Cell Mol Physiol. 2015 Apr 15;308(8):L776-87. doi: 10.1152/ajplung.00334.2014. Epub 2015 Feb 20.

4.

The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis.

Birmpas C, Briand JP, Courty J, Katsoris P.

Vasc Cell. 2012 Dec 24;4(1):21. doi: 10.1186/2045-824X-4-21.

5.

Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L.

Birmpas C, Briand JP, Courty J, Katsoris P.

BMC Cell Biol. 2012 Nov 13;13:32. doi: 10.1186/1471-2121-13-32.

6.

A simple approach to cancer therapy afforded by multivalent pseudopeptides that target cell-surface nucleoproteins.

Destouches D, Page N, Hamma-Kourbali Y, Machi V, Chaloin O, Frechault S, Birmpas C, Katsoris P, Beyrath J, Albanese P, Maurer M, Carpentier G, Strub JM, Van Dorsselaer A, Muller S, Bagnard D, Briand JP, Courty J.

Cancer Res. 2011 May 1;71(9):3296-305. doi: 10.1158/0008-5472.CAN-10-3459. Epub 2011 Mar 17.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk